EVALUATING THE RISK-BENEFIT PROFILE OF RIVAROXABAN VERSUS WARFARIN IN STROKE PREVENTION AMONG ELDERLY PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION; A RETROSPECTIVE COHORT STUDY
{"title":"EVALUATING THE RISK-BENEFIT PROFILE OF RIVAROXABAN VERSUS WARFARIN IN STROKE PREVENTION AMONG ELDERLY PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION; A RETROSPECTIVE COHORT STUDY","authors":"Dr Absar Khalid Mir","doi":"10.53555/jptcp.v31i6.6611","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":507885,"journal":{"name":"Journal of Population Therapeutics & Clinical Pharmacology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Population Therapeutics & Clinical Pharmacology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.53555/jptcp.v31i6.6611","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}